These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 2138998

  • 21. Differential effects of lipoxygenase products on FMLP and LTB4 evoked neutrophil aggregation.
    Beckman JK, Gay JC, Brash AR, Lukens JN, Oates JA.
    Lipids; 1985 Jun; 20(6):357-60. PubMed ID: 2991693
    [Abstract] [Full Text] [Related]

  • 22. G protein activation and mediator release from human neutrophils and platelets after stimulation with sodium fluoride and receptor-mediated stimuli.
    Brom C, Brom J, König W.
    Immunology; 1991 Jul; 73(3):287-92. PubMed ID: 1652553
    [Abstract] [Full Text] [Related]

  • 23. Effects of protein I of Neisseria gonorrhoeae on neutrophil activation: generation of diacylglycerol from phosphatidylcholine via a specific phospholipase C is associated with exocytosis.
    Haines KA, Reibman J, Tang XY, Blake M, Weissmann G.
    J Cell Biol; 1991 Aug; 114(3):433-42. PubMed ID: 1907286
    [Abstract] [Full Text] [Related]

  • 24. A flow-cytometric method to evaluate drug antiaggregating effect on rat neutrophils.
    Capezzone de Joannon A, Mangano G, Peri G, Rossi V, Milanese C.
    J Pharmacol Toxicol Methods; 1996 Sep; 36(1):21-8. PubMed ID: 8872915
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
    Harvath L, McCall CE, Bass DA, McPhail LC.
    J Immunol; 1987 Nov 01; 139(9):3055-61. PubMed ID: 2822802
    [Abstract] [Full Text] [Related]

  • 26. The inactivation of the polymorphonuclear leukocyte by non-steroidal anti-inflammatory drugs.
    Abramson S, Edelson H, Kaplan H, Given W, Weissmann G.
    Inflammation; 1984 Jun 01; 8 Suppl():S103-8. PubMed ID: 6090311
    [Abstract] [Full Text] [Related]

  • 27. Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs.
    Díaz-González F, González-Alvaro I, Campanero MR, Mollinedo F, del Pozo MA, Muñoz C, Pivel JP, Sánchez-Madrid F.
    J Clin Invest; 1995 Apr 01; 95(4):1756-65. PubMed ID: 7535797
    [Abstract] [Full Text] [Related]

  • 28. Pro-inflammatory and anti-inflammatory effects of the stable prostaglandin D2 analogue, ZK 118.182.
    Pons F, Williams TJ, Kirk SA, McDonald F, Rossi AG.
    Eur J Pharmacol; 1994 Aug 22; 261(3):237-47. PubMed ID: 7813544
    [Abstract] [Full Text] [Related]

  • 29. Inhibition by nonsteroidal anti-inflammatory drugs of superoxide production and granule enzyme release by polymorphonuclear leukocytes stimulated with immune complexes or formyl-methionyl-leucyl-phenylalanine.
    Neal TM, Vissers MC, Winterbourn CC.
    Biochem Pharmacol; 1987 Aug 01; 36(15):2511-7. PubMed ID: 3038127
    [Abstract] [Full Text] [Related]

  • 30. Prevention of cytokine-induced changes in leukocyte adhesion receptors by nonsteroidal antiinflammatory drugs from the oxicam family.
    García-Vicuña R, Díaz-González F, González-Alvaro I, del Pozo MA, Mollinedo F, Cabañas C, González-Amaro R, Sánchez-Madrid F.
    Arthritis Rheum; 1997 Jan 01; 40(1):143-53. PubMed ID: 9008610
    [Abstract] [Full Text] [Related]

  • 31. Chemoattractant-induced release of elastase by tumor necrosis factor-primed human neutrophils: auto-regulation by endogenous adenosine.
    Ottonello L, Amelotti M, Barbera P, Dapino P, Mancini M, Tortolina G, Dallegri F.
    Inflamm Res; 1999 Dec 01; 48(12):637-42. PubMed ID: 10669115
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of NADPH-oxidase activity in human polymorphonuclear neutrophils by lipophilic ascorbic acid derivatives.
    Schmid E, Figala V, Ullrich V.
    Mol Pharmacol; 1994 May 01; 45(5):815-25. PubMed ID: 8190099
    [Abstract] [Full Text] [Related]

  • 33. Effect of diclofenac sodium, tolfenamic acid and indomethacin on the production of superoxide induced by N-formyl-methionyl-leucyl-phenylalanine in normal human polymorphonuclear leukocytes.
    Friman C, Johnston C, Chew C, Davis P.
    Scand J Rheumatol; 1986 May 01; 15(1):41-6. PubMed ID: 3008321
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cocaine and its derivatives blunt neutrophil functions without influencing phosphorylation of a 47-kilodalton component of the reduced nicotinamide-adenine dinucleotide phosphate oxidase.
    Haines KA, Reibman J, Callegari PE, Abramson SB, Philips MR, Weissmann G.
    J Immunol; 1990 Jun 15; 144(12):4757-64. PubMed ID: 2161879
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of some human neutrophil functions by the cyclooxygenase inhibitor ketorolac tromethamine.
    Hyers TM, Tricomi SM, Liao JJ.
    J Leukoc Biol; 1992 May 15; 51(5):490-5. PubMed ID: 1318350
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. NPC 15669-modulated human polymorphonuclear neutrophil functional responsiveness: effects on receptor-coupled signal transduction.
    Smith RJ, Justen JM, Bleasdale JE, Sly LM.
    Br J Pharmacol; 1995 Apr 15; 114(8):1694-702. PubMed ID: 7599938
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.